新华制药公告,第十一届董事会2025年第一次临时会议于二零二五年九月二十六日以书面传签方式召开,应参会董事9名,实际参会董事9名。会议审议并通过了关于召开2025年第一次临时股东大会的议案,9名董事一致赞成本议案,无反对或弃权票。股东大会通知将另行公告。
Source Link新华制药公告,第十一届董事会2025年第一次临时会议于二零二五年九月二十六日以书面传签方式召开,应参会董事9名,实际参会董事9名。会议审议并通过了关于召开2025年第一次临时股东大会的议案,9名董事一致赞成本议案,无反对或弃权票。股东大会通知将另行公告。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.